Use access key #2 to skip to page content.

Manifest (92.60)

Recs

0

Favorite Screens: Launch Pad Logic 2017

December 09, 2016 – Comments (0) | RELATED TICKERS: GSK , BUD , AMZN

We'll add GlaxoSmithKline (GSK) to our long-term CAPS tracking portfolio as a result of this screening technique that seeks the highest year-over-year (2017 vs. 2016) EPS changes -- while sticking to the Best Companies.  https://expectingalpha.com/2016/12/09/favorite-screens-launch-pad-2017/

Recs

1

Screening by Escape Velocity

December 08, 2016 – Comments (0) | RELATED TICKERS: ABBV

Every year, we run a stock selection challenge at www.manifestinvesting.com that starts and ends on Groundhog Day, year over year.  There's an individual and group competition.  A group from St. Louis (Broad Assets) has won 3-of-the-last-4 group championships and it appears they favor stocks with good long term prospects in combination with "launch pad earnings" for this year vs. last year.  For more, see: https://expectingalpha.com/2016/12/08/fave-five-escape-velocity/ We're adding Abbvie (ABBV) as part of this week's hunt.  [more]

Recs

1

Teva Pharma (TEVA)

December 01, 2016 – Comments (0) | RELATED TICKERS: TEVA

The Street is wrecked over the Actavis integration and Copaxone competition.  Teva Pharma (TEVA) is a gorilla and the 3-5 year outlook is pretty good.  The Value Line low total return forecast is approximately 15% and TEVA landed at the top of of this week's Fave Five: https://expectingalpha.com/2016/12/01/fave-five-1222016-2/  [more]

Recs

1

Fave Five Best Small Companies for 2017

November 04, 2016 – Comments (0) | RELATED TICKERS: FWRD , MELI , MLAB

Adding Mercadolibre (MELI), Mesa Labs (MLAB) and Forward Air (FWRD) to our CAPS tracking portfolio.

https://expectingalpha.com/2016/11/04/fave-five-1142016/

Recs

1

Novo Nordisk (NVO)

October 14, 2016 – Comments (0) | RELATED TICKERS: NVO

World leader in diabetes solutions.  Our financial analysis summarized at: https://expectingalpha.com/2016/10/07/novo-nordisk-nvo/

Featured Broker Partners


Advertisement